Regular Article
1,25-Dihydroxycholecalciferol Enhances Butyrate-Induced p21Waf1/Cip1 Expression

https://doi.org/10.1006/bbrc.2001.4756Get rights and content

Abstract

Butyrate, a short-chain fatty acid produced in the colon, as well as its prodrug tributyrin, reduce proliferation and increase differentiation of colon cancer cells. p21Waf1/Cip1 and p27Kip1 are negative regulators of cell cycle and are thought to have a key function in the differentiation of various cell lines. We studied the effects of butyrate on differentiation, VDR expression, as well as on p21Waf1/Cip1 and p27Kip1 expression in human colon cancer cells (Caco-2). Butyrate induced cell differentiation, which was further enhanced after addition of 1,25-dihydroxycholecalciferol. Synergistic effect of butyrate and dihydroxycholecalciferol in Caco-2 cells was due to butyrate-induced overexpression of VDR. While butyrate as well as dihydroxycholecalciferol increased p21Waf1/Cip1 and p27Kip1 expression, in contrast combined exposure of butyrate and dihydroxycholecalciferol resulted in a synergistic amplification of p21Waf1/Cip1, but not of p27Kip1 expression. These data imply that butyrate selectively increases p21Waf1/Cip1 expression via upregulation of VDR in Caco-2 cells.

References (32)

  • I. Nathan et al.

    Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: Dependency on the inducing agent

    Exp. Cell Res.

    (1998)
  • M.L. Fero et al.

    A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27 (Kip1)-deficient mice

    Cell

    (1996)
  • S.Y. Archer et al.

    p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells

    Proc. Natl. Acad. Sci. USA

    (1998)
  • D.A. Litvak et al.

    Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1

    Surgery

    (1998)
  • J.Q. Tian et al.

    Involvement of p21 (WAF1/Cip1) and p27 (Kip1) in intestinal epithelial cell differentiation

    Am. J. Physiol.

    (1999)
  • Cited by (29)

    • Vitamin D Receptor Signaling and Cancer

      2017, Endocrinology and Metabolism Clinics of North America
      Citation Excerpt :

      The interactions of transcriptional corepressors such as NCOR1 and NCOR2/SMRT have been examined to investigate this possibility.61,256–261 In turn, altered VDR–corepressor interactions may form a molecular lesion that could be targeted by cotreatment of 1,25(OH)2D3 plus the HDAC inhibitors.262–267 Biology is very clearly in the genomic era, in which the sum total of genes, transcripts, proteins and metabolites in cells are captured and analyzed.

    • Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression

      2017, Journal of Steroid Biochemistry and Molecular Biology
      Citation Excerpt :

      High vitamin D status has been proposed as protective against colon cancer by exerting anti-cancer mechanisms through the biologically active form of vitamin D, 1α,25-dihydroxyvitamin D (1,25(OH)2D) [1]. For example, in Caco-2 colon cancer cells, 1,25(OH)2D inhibited cell proliferation by decreasing EGF receptor expression, activating the TGF-β pathway, and increasing p21 expression [2–4]. 1,25(OH)2D regulates transcription of anti-cancer genes by binding to the vitamin D receptor (VDR), a member of the nuclear receptor superfamily that heterodimerizes with one of the three retinoid X receptor (RXR) isoforms (α, β, and γ) and binds to vitamin D response elements (VDREs) in the promoters of vitamin D responsive genes [5].

    • Vitamin D: Cancer and differentiation

      2011, Vitamin D: Two-Volume Set
    View all citing articles on Scopus

    Abbreviations used: AP, alkaline phosphatase; cdk, cyclin-dependent kinase; VDR, vitamin D receptor.

    1

    To whom correspondence should be addressed at Division of Gastroenterology and Clinical Nutrition, Second Department of Internal Medicine, Johann Wolfgang Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. Fax: +49-69-6301-6448. E-mail: [email protected].

    View full text